 
Thursday, February 2, 2012
Gene Sequence 3
Alzheimer's disease (AD) patients with an inherited form of the disease   carry mutations in the presenilin proteins (PSEN1 or PSEN2) or the   amyloid precursor protein (APP). These disease-linked mutations result   in increased production of the longer form of amyloid-beta (main   component of amyloid deposits found in AD brains). Presenilins are   postulated to regulate APP processing through their effects on   gamma-secretase, an enzyme that cleaves APP. Also, it is thought that   the presenilins are involved in the cleavage of the Notch receptor such   that, they either directly regulate gamma-secretase activity, or   themselves act are protease enzymes.
Subscribe to:
Post Comments (Atom)
 
No comments:
Post a Comment